15 December 2025
With the BSR embarking on a year-long exploration of our specialty’s rich history, it is fitting to begin with one of the most influential figures in British rheumatology: Richard Michael Mason (1917–1977). Richard helped to shape the specialty during a period of rapid scientific and clinical development. His work continues to influence research, education and patient care across the UK. Today his legacy lives on through the Michael Mason Award, one of BSR’s most prestigious awards for early career researchers.
Early years of a pioneer
Born in London, he studied at Marlborough, Christ Church Oxford and St Bartholomew’s Hospital, qualifying in 1942. During the Second World War he trained as a pilot with the Oxford University Air Squadron and then joined the RAF as a medical officer, serving in Germany and Denmark.
After the war he returned to Bart’s as a medical registrar and soon committed to the emerging area of rheumatology. He worked with leading clinicians of the time and helped shape the new identity of the specialty. His consultant roles at the West London Hospital, Chase Farm Hospital and the London Hospital placed him at the forefront of clinical and research progress. He later served as civil consultant in rheumatology to the RAF.
Leadership in research and professional development
Mason played an important part in raising the profile of rheumatology research in the UK. He served as President of the British Association of Physical Medicine and Rheumatology from 1968 to 1971 and became President of the Heberden Society in 1974. As chair of the executive committee of the Arthritis and Rheumatism Council from 1971, he supported major investment in research facilities and helped expand the charity’s scientific impact. His own academic work ranged from drug trial design to orthopaedic collaboration and innovations in clinical communication.
He was also known as an exceptional teacher. His lectures were practical, engaging and memorable, and he inspired many clinicians who later became leaders in the field.
The Michael Mason Award
The Michael Mason Award continues this commitment to excellence by recognising outstanding early career researchers who are developing original work in clinical or scientific rheumatology. It remains one of the most significant research awards in the specialty.
Winners present their research at BSR Annual Conference, the UK’s leading gathering for rheumatology professionals. The 2026 award is now open for submissions, closing on 23 January 2026, and the winner will present in Glasgow from 28-30 April.
The award not only honours Mason’s contribution but also supports the next generation of researchers who are advancing rheumatology through innovative thinking and high-quality evidence.